logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Haohai Biological Technology (06826.HK) spent approximately HK$432,600 to repurchase 15,600 shares on November 10th.

date
10/11/2025
China Fortune Financial News APP information, Haohai Biotechnology (06826.HK) announced that on November 10, 2025, it spent about 432,600 Hong Kong dollars to repurchase 15,600 shares.
Latest
2 m ago
Barrick Gold: In the third quarter of 2025, the dividend per share is $0.175, including an earnings dividend of $0.05 per share.
2 m ago
Shanghai cracks down on illegal modification of electric bicycles, with over 31,000 cases investigated and dealt with this year.
3 m ago
Songyuan Security: One of the controlling shareholders and concerted actors plan to reduce their holdings in the company by no more than 1%.
3 m ago
Barrick Gold: Increase quarterly base dividend by 25% to $0.125 per share.
4 m ago
Market news: The EU is discussing new sanctions against Russia, but the measures may not be implemented this year.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.